Ocean Biomedical, Inc. (OCEA): auditor change — Ocean Biomedical dismisses Deloitte & Touche as independent auditor effective Dec. 2, 2024

Ocean Biomedical, Inc.

Dismissed Deloitte & Touche LLP as independent registered public accounting firm effective December 2, 2024.
No disagreements with Deloitte on accounting principles, financial statement disclosure, or audit scope during fiscal 2022–2023 or interim period through Dec. 2, 2024.
Deloitte's prior reports contained a going concern explanatory paragraph citing working capital deficiency and anticipated losses.
Board approved the change by written consent on December 2, 2024.
Company requested Deloitte to furnish a letter to the SEC agreeing with the statements; letter attached as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.98

Ocean Biomedical, Inc. dismissed Deloitte & Touche LLP as its auditor.

Action: dismissal
Auditor: Deloitte & Touche LLP

Exact text from the filing

(the “Company”) has dismissed Deloitte & Touche LLP (the “Former Accounting Firm”) as its independent registered public accounting firm, effective as of December 2, 2024.

View on SEC.gov

Browse all auditor changes →

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-049099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.